Healthcare

FDA panel endorses Pfizer vaccine for public use in final step before authorization

By Cassidy Morrison
Published December 10, 2020 10:43pm ET
Add Washington Examiner on Google
FDA panel endorses Pfizer vaccine for public use in final step before authorization
Food and Drug Administration vaccine experts recommended that Pfizer’s coronavirus vaccine be authorized for public use, the final step before the agency issues its emergency use authorization as early as Friday. The Vaccines and Related Biological Products Advisory Committee voted Thursday to endorse the vaccine created by Pfizer and BioNTech for emergency use authorization 17-4, […]

Food and Drug Administration vaccine experts recommended that Pfizer’s coronavirus vaccine be authorized for public use, the final step before the agency issues its emergency use authorization as early as Friday.

The Vaccines and Related Biological Products Advisory Committee voted Thursday to endorse the vaccine created by Pfizer and BioNTech for emergency use authorization 17-4, with one abstention. If the agency grants the EUA on Friday, shots will start moving out to states within 24 hours, and immunizations could begin next week.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

COVID-19 FDA Pfizer Vaccines